David Bruyette, DVM

Diabetes in Humans and Animals
Diabetes in Humans and Animals

A Q&A with Anivive’s Chief Medical Officer, Dr. David Bruyette.

David Bruyette, DVM
Logo
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
David Bruyette, DVM
Logo
Effect of Feeding an Iodine-Restricted Diet in Cats with Spontaneous Hyperthyroidism
David Bruyette, DVM
Logo
Phase 1 Dose-Escalation Study with LEC/chTNT-3 and Toceranib Phosphate (Palladia(®)) in Dogs with Spontaneous Malignancies
David Bruyette, DVM
Logo
Comparison of intravenous versus intramuscular administration of corticotropin-releasing hormone in healthy cats
David Bruyette, DVM
Logo
2016 AAFP Guidelines for the Management of Feline Hyperthyroidism
David Bruyette, DVM
Logo
Trilostane therapy for treatment of spontaneous hyperadrenocorticism in cats: 15 cases (2004-2012)
David Bruyette, DVM
Logo
Expected total thyroxine (TT4) concentrations and outlier values in 531,765 cats in the United States (2014-2015)
David Bruyette, DVM

Authors